We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
Publication, Part of Prescribing Costs in Hospitals and the Community
Hospital Prescribing - England, 2011
Official statistics- Publication Date:
- 14 Nov 2012
- Geographic Coverage:
- England
- Geographical Granularity:
- Regions, Country, Strategic Health Authorities
- Date Range:
- 01 Jan 2011 to 31 Dec 2011
Summary
This report compares expenditure between primary and secondary care in total and for selected areas, including medicines positively appraised by NICE. The specific area covered this year is medicines for HIV and AIDs.
An error has been identified with the figures given in table 4 for alendronic acid and rosiglitazone in the original publication released in November 2012. Corrected versions of the report and the Excel spreadsheet replaced the incorrect versions on 25th March 2013
Highlights
- Total prescribing costs in 2011 were £13.1 billion
- In 2011 hospital use accounted for 33.3 per cent of the total cost, up from 31.79 percent in 2010.
- The cost of medicines rose by 1.9 per cent overall but by 6.9 per cent in hospitals
- Of the drugs positively appraised by NICE, the greatest overall cost was for atorvastatin but adalimumab incurred the greatest cost in hospitals.
- HIV/AIDS treatment is given predominantly through hospitals but while the total cost varies widely, cost per patient is similar
Resources
Last edited: 2 November 2018 2:49 pm